Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Eight-Week, Multicenter, Double-blind, Placebo-controlled Study Evaluating the Efficacy, Safety, and Tolerability of One Fixed 100 mg Dose of Saredutant in Patients With Major Depressive Disorder.

NCT00250614 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00250614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00250614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Eight-Week, Multicenter, Double-blind, Placebo-controlled Study Evaluating the Efficacy, Safety, and Tolerability of One Fixed 100 mg Dose of Saredutant in Patients With Major Depressive Disorder.
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2005
Completion date
October 31, 2006
Enrollment
452 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder